Rumors of Biogen’s disagreements with Eisai have been greatly exaggerated, CEO Chris Viehbacher said during a second quarter ...

Onvansertib combined with standard care showed up to 49% confirmed ORR in RAS-mutated colorectal cancer, with early signs of ...

Mastercard shares are up about 6% so far this year, which Jeffrey flagged was about 5 percentage points behind Visa's stock gain. "We contend that a strong global economy will power a catch-up trade," ...

Design and product development platform Figma (FIG) priced its IPO at $33 on Wednesday, which is $1 above the top end of its ...

Meta's strong earnings report sent its stock soaring after hours. The company also made it clear that the AI talent wars come ...

Vinay Prasad, head of the Center for Biologics Evaluation and Research (CBER) at the US Food and Drug Administration (FDA), ...

Tomorrow, July 31, 2025, Figma plans to begin trading on the New York Stock Exchange under the ticker symbol "FIG." ...

Data analytics firm Verisk said on Wednesday it will buy AccuLynx, which makes software for roofing contractors, for $2.35 ...

Specific product category performance included soils (up 12%), mulch (up 8%), controls (up 3%), and branded lawn fertilizers (up 1%). Lawn fertilizer product Halts saw a 25% unit increase, and grass ...

Multiple firms including RBC Capital, Piper Sandler, UBS, Guggenheim, BTIG, and William Blair downgraded CyberArk to "Neutral" or equivalent ratings, though several raised their price targets to ...

Data analytics provider Verisk is acquiring SaaS platform AccuLynx for $2.35bn in cash, the company said in a statement. The ...

Fed holds rates steady, Microsoft nears $4 trillion valuation, Meta’s earnings blowout, and more news to start your day.